The Patent Finder
LT

Lockbody Therapeutics Ltd.

First filing 2020
OverviewNotableFeesChangesFamiliesPatent listSources & methods

One patent currently held, every record listed here

1 more in force is now held by another company
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
25 more records may belong here and await a decision; they are not counted.

The next term ends in Apr 2039. from the record

Of the 1 now held by other companies, 1 name Centessa Pharmaceuticals UK Limited as their current owner. Each row says so.

Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
0
Ending by 2030
Apr 2039
Next term end
1
Patent families

When these terms end

Each bar runs from grant to computed term end. 2023 to 2039.
US 12,415,861 Anti C-Met Antibodies Apr 19, 2039
US 11,673,960 Anti C-Met Antibodies May 16, 2039
202620292032203520382039
1 pending application: term is not computable until grant.Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know

Notable patents

Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Only 1 of the currently held patents qualifies as notable.

Formerly held, still cited

Notable
The most cited patent in this portfolio, cited by 3 later US patents, top 25% of utility patents granted in 2023 in our data. Protection runs to 2039.
Ends May 2039 · High confidence

Fee deadlines

No maintenance fee falls due on this company's record before Nov 10, 2027.

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

What they patent

Grouped by real patent family, largest first, labeled by the earliest filing in each. No technology classification is inferred from titles.
Anti C-Met Antibodies1 in forceto Apr 2039

Patents held now

Soonest term end first.

Showing 1 to 1 of 1

PatentTitleStatusExpiresConfidence
US 12,415,861Anti C-Met Antibodies
In force
 · High confidence
In forceHigh confidence
Also on record, not counted in the 1: 1 patent in force now held by others · 1 application pending. List them

Sources and methods

Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited